诊断学理论与实践 ›› 2026, Vol. 25 ›› Issue (03): 315-320.doi: 10.16150/j.1671-2870.2026.03.007
李琼a, 刘富强a, 邱罗平a, 李少芬a, 姚利飞a, 彭卫a, 范家亮b, 徐仙赟a(
)
收稿日期:2026-01-17
修回日期:2026-05-13
接受日期:2026-05-18
出版日期:2026-06-25
发布日期:2026-06-27
通讯作者:
徐仙赟 E-mail:xuxianyun_1982@163.com作者简介:作者贡献/Authors’ Contributions
李琼进行病例收集、数据采集、分析/解析,论文撰写;刘富强、邱罗平、姚利飞、彭卫、李少芬进行病例检测、数据采集及检验学诊断;范家亮参与论文病例讨论;徐仙赟指导论文写作和修改,并对文章的知识性内容作批评性审阅。
基金资助:
LI Qionga, LIU Fuqianga, QIU Luopinga, LI Shaofena, YAO Lifeia, PENG Weia, FAN Jialiangb, XU Xianyuna(
)
Received:2026-01-17
Revised:2026-05-13
Accepted:2026-05-18
Published:2026-06-25
Online:2026-06-27
摘要:
目的:总结不典型流行区恙虫病患者的临床特征,并探讨宏基因组二代测序(metagenomic next-generation sequencing, mNGS)及靶向二代测序(targeted next-generation sequencing, tNGS)在病原学诊断中的应用价值。方法:回顾性分析2025年5月至2026年1月间,吉安市中心人民医院经二代测序(next-generation sequencing, NGS)确诊的7例恙虫病患者的临床资料。其中,以呼吸道症状或肺部感染为主要表现者采用tNGS检测(3例),以脓毒症或全身性感染为主要表现者采用mNGS检测(4例)。收集患者临床表现、实验室检查、NGS结果、诊断时间及治疗转归等资料。结果:7例患者中男性4例,女性3例,中位年龄69岁。所有患者均因高热起病,仅1例存在典型焦痂。5例患者存在血小板减少,7例患者均存在C反应蛋白升高及肝功能异常。NGS均于送检后24~72 h内检出恙虫病东方体序列。患者自入院至获得病原学结果时间为2~4 d,中位时间3 d。根据NGS结果调整为多西环素或米诺环素治疗后,患者体温于1~3 d内恢复正常,中位退热时间2 d,全部患者均治愈出院。结论:不典型流行区恙虫病患者临床表现缺乏特异性,易误诊、漏诊。对于经验性抗感染治疗无效、病因未明的高危发热患者,NGS可作为重要的补充诊断手段。适时送检NGS可实现快速病原学精准识别,为后续调整精准抗感染方案提供关键依据。
中图分类号:
李琼, 刘富强, 邱罗平, 李少芬, 姚利飞, 彭卫, 范家亮, 徐仙赟. 不典型流行区7例恙虫病患者的临床表现及宏基因组与靶向二代测序的应用[J]. 诊断学理论与实践, 2026, 25(03): 315-320.
LI Qiong, LIU Fuqiang, QIU Luoping, LI Shaofen, YAO Lifei, PENG Wei, FAN Jialiang, XU Xianyun. Clinical manifestations of scrub typhus in atypical endemic areas and application of metagenomic and targeted next-generation sequencing: an analysis of seven cases[J]. Journal of Diagnostics Concepts & Practice, 2026, 25(03): 315-320.
表1
7例恙虫病东方体感染患者关键实验室检查结果
| Laboratory parameter | Median | Interquartile range(25th-75th percentile) | Range |
|---|---|---|---|
| C-reactive protein(mg/L) | 77.53 | 59.3-103.4 | 20.26-159.85 |
| Procalcitonin(ng/mL) | 1.34 | 1.02-1.53 | 0.71-8.23 |
| Platelet count(×10⁹/L) | 94 | 51.0-99.0 | 30-185 |
| Albumin(g/L) | 28.5 | 25.2-29.6 | 20.5-34.2 |
| Alanine aminotransferase(U/L) | 98 | 60.0-108.0 | 56-112 |
| Aspartate aminotransferase(U/L) | 139 | 95.0-140.0 | 83-169 |
| Sodium(mmol/L) | 131.9 | 131.9-135.3 | 129.8-135.8 |
| D-dimer(mg/L) | 6.59 | 3.14-6.94 | 1.94-10.40 |
表2
7例恙虫病东方体感染患者NGS检测策略与关键结果
| Case No. | Sample type | Sequencing method | Other detected pathogens (excluding O. tsutsugamushi) | Sequence reads of O. tsutsugamushi | Turnaround time(hours) |
|---|---|---|---|---|---|
| 1 | Bronchoalveolar lavage fluid | tNGS | Acinetobacter baumannii; Pseudomonas aeruginosa; HSV-1 | 24 | -48 |
| 2 | Bronchoalveolar lavage fluid | tNGS | Escherichia coli; Epstein-Barr virus | 754 | -48 |
| 3 | Bronchoalveolar lavage fluid | tNGS | None | 4 | -24 |
| 4 | Plasma | mNGS | Epstein-Barr virus | 27 | -48 |
| 5 | Plasma | mNGS | Parvovirus B19 | 66 | -48 |
| 6 | Plasma | mNGS | Epstein-Barr virus; Human polyomavirus type 2 | 1089 | -8 |
| 7 | Plasma | mNGS | Epstein-Barr virus; HSV-1; Hepatitis B virus | 287 | -48 |
表3
7例恙虫病东方体感染患者治疗调整与转归
| Case No. | Empirical therapy (Before adjustment) | NGS-guided targeted therapy | Time to defervescence after adjustment | Trend of key inflammatory markers | Length of hospital stay (days) | Final outcome |
|---|---|---|---|---|---|---|
| 1 | Meropenem; Moxifloxacin | Doxycycline | Within 72 h | CRP: 77.53 → 18.60 mg/L | 8 | Recovered and discharged |
| 2 | Ceftriaxone; Levofloxacin | Levofloxacin + Doxycycline | Within 72 h | CRP: 103.4 → 5.61 mg/L; PCT: 8.23 → 0.18 ng/mL | 8 | Recovered and discharged |
| 3 | Piperacillin-tazobactam | Minocycline added | Within 48 h | CRP: 59.3 mg/L → Normal | 7 | Recovered and discharged |
| 4 | Cefoperazone-sulbactam | Doxycycline | Improved after report release | Overall inflammatory markers improved | 13 | Recovered and discharged |
| 5 | Moxifloxacin → Imipenem-cilastatin | Meropenem + Doxycycline | Controlled after stabilization | CRP and PCT gradually decreased | 17 | Recovered and discharged |
| 6 | Piperacillin-tazobactam | Doxycycline | Within 72 h | CRP and PCT markedly decreased | 15 | Recovered and discharged |
| 7 | Cefoperazone-sulbactam | Doxycycline | Within 48 h | Inflammatory markers improved | 10 | Recovered and discharged |
| [1] | LIAO C C, TSAI C H, LO H R, et al. Development of a scrub typhus diagnostic platform incorporating cell-surface display technology[J]. Front Immunol, 2021,12:761136. |
| [2] | 张鲁燕, 毕振旺, 赵仲堂. 我国恙虫病东方体分子流行病学研究进展[J]. 中华流行病学杂志, 2014, 35(1):88-92. |
| ZHANG L Y, BI Z W, ZHAO Z T. Recent advances in molecular epidemiology of Orientia tsutsugamushi in China[J]. Chin J Epidemiol, 2014, 35(1):88-92. | |
| [3] | KIM C M, KIM D M, YUN N R. Evaluation of the diagnostic accuracy of antibody assays for patients with scrub typhus[J]. J Clin Microbiol, 2021, 59(7):e02942-e02920. |
| [4] | 朱丽娜, 张晶波, 陈梅玲, 等. 实时荧光定量PCR检测恙虫病东方体[J]. 中国人兽共患病学报, 2006, 22(3):228-231. |
| ZHU L N, ZHANG J B, CHEN M L, et al. Detection of Orientia tsutsugamushi by quantitative real-time PCR assay[J]. Chin J Zoonoses, 2006, 22(3):228-231. | |
| [5] | SUN C B, MA Z, LIU Z. Case Report: Optic neuritis as the initial presentation of Orientia tsutsugamushi infection detected by metagenomic next-generation sequencing[J]. Front Immunol, 2023,14:1129246. |
| [6] |
QIAN P, HE X, YANG M, et al. Detection of severe murine typhus by nanopore targeted sequencing, China[J]. Emerg Infect Dis, 2023, 29(6):1275-1277.
doi: 10.3201/eid2906.221929 pmid: 37209688 |
| [7] | 中华医学会检验医学分会. 高通量宏基因组测序技术检测病原微生物的临床应用规范化专家共识[J]. 中华检验医学杂志, 2020, 43(12):1181-1195. |
| Chinese Society of Laboratory Medicine. Expert consensus on clinical standardized application of metagenomics next-generation sequencing for detection of pathogenic microorganisms[J]. Chin J Lab Med, 2020, 43(12):1181-1195. | |
| [8] | WALKER D H, MENDELL N L. A scrub typhus vaccine presents a challenging unmet need[J]. npj Vaccines, 2023,8:11. |
| [9] |
ABERNATHY H A, URSERY L, MERDJANE B A, et al. OrientiatsutsugamushiAntibodies in patients with eschars and suspected tickborne disease[J]. Emerg Infect Dis, 2025, 31(11):2187-2190.
doi: 10.3201/eid3111.250763 URL |
| [10] |
BLAIR P W, KOBBA K, OKELLO S, et al. Evidence of Orientia spp. endemicity among severe infectious disease cohorts, Uganda[J]. Emerg Infect Dis, 2024, 30(7):1442-1446.
doi: 10.3201/eid3007.231040 pmid: 38916638 |
| [11] |
NIU Y, CHEN S, WANG G, et al. Dual-genotype Orientia tsutsugamushi infections, Hainan Island, China, 2023[J]. Emerg Infect Dis, 2025, 31(6):1222-1225.
doi: 10.3201/eid3106.241967 pmid: 40439516 |
| [12] | 赵芷若, 周东明, 操敏, 等. 恙虫病东方体混合重组抗原应用于胶体金免疫层析试纸条的制备及效价检测[J]. 生物加工过程, 2024, 22(2):196-203. |
| ZHAO Z R, ZHOU D M, CAO M, et al. Establishment of colloidal gold immunochromatographic assay to detect the antibody against Orientia tsutsugamushi[J]. Chin J Bioprocess Eng, 2024, 22(2):196-203. | |
| [13] | ZHAO X, LAI X, YAN B, et al. A novel photoelectrochemical biosensor for sensitive detection of nucleic acids based on recombinase polymerase amplification and 3D-array titania nanorods[J]. Int J Biol Macromol, 2025,296:139528. |
| [14] | KALA D, SHARMA T K, GUPTA S, et al. Development of paper-based DNA sensor for detection of O. tsutsugamushi using sustainable GQDs@AuNPs nanocomposite[J]. Chemosphere, 2022,300:134428. |
| [15] |
WANG L, ZHAO Z, ZHAO Y, et al. Comparative diagnostic accuracy of metagenomic next-generation sequencing and targeted next-generation sequencing for periprosthetic joint infection: A systematic review and meta-analysis[J]. J Infect, 2025, 91(6):106661.
doi: 10.1016/j.jinf.2025.106661 URL |
| [16] | BASHARAT Z, AKHTAR U, KHAN K, et al. Differential analysis of Orientia tsutsugamushi genomes for therapeutic target identification and possible intervention through natural product inhibitor screening[J]. Comput Biol Med, 2022,141:105165. |
| [17] |
DAMODAR T, SINGH B, PRABHU N, et al. Association of scrub typhus in children with acute encephalitis syndrome and meningoencephalitis, southern India[J]. Emerg Infect Dis, 2023, 29(4):711-722.
doi: 10.3201/eid2904.221157 pmid: 36957990 |
| [18] |
MALAPELLE U, LEIGHL N, ADDEO A, et al. Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer[J]. Br J Cancer, 2024, 131(2):212-219.
doi: 10.1038/s41416-024-02709-4 |
| [19] |
DE VRIES S G, VAN EEKEREN L E, VAN DER LINDEN H, et al. Searching and finding the hidden treasure: A retrospective analysis of rickettsial disease among Dutch international travelers[J]. Clin Infect Dis, 2021, 72(7):1171-1178.
doi: 10.1093/cid/ciaa091 pmid: 31998942 |
| [1] | 朱维维, 李倩, 吴凡, 翟志敏. 100例骨髓增生异常性肿瘤患者基因突变及其与临床特征间的关系[J]. 诊断学理论与实践, 2024, 23(03): 305-312. |
| [2] | 杜云志, 冯菁华, 常春康. 二代测序技术在骨髓增生异常综合征临床诊断和治疗决策中的应用进展[J]. 诊断学理论与实践, 2019, 18(06): 685-671. |
| [3] | 宋元林, 侯东妮. 支气管扩张症患者气道、肠道微生态的研究及临床价值[J]. 诊断学理论与实践, 2019, 18(05): 503-508. |
| [4] | 李蕾, 吴希, 许冠群, 梁茜, 戴菁, 武文漫, 丁秋兰, 王鸿利, 王学锋. 基于新一代测序技术的易栓症基因检测Panel的建立及其在中国静脉血栓患者遗传背景研究中的临床应用[J]. 诊断学理论与实践, 2019, 18(04): 394-401. |
| [5] | 冯国栋, 贺旻, 汪昕. 二代测序技术在诊断神经系统感染性疾病中的应用[J]. 诊断学理论与实践, 2018, 17(04): 391-395. |
| [6] | 陈冰, 眭竫旎. 急性髓系白血病微小残留病监测方式的展望[J]. 诊断学理论与实践, 2017, 16(01): 17-26. |
| [7] | 宋陆茜, 常春康. 二代测序技术在骨髓增生异常综合征诊治中的临床应用[J]. 诊断学理论与实践, 2016, 15(06): 556-560. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||